← Back to news
GrantNIH_REPORTERMonday, May 11, 2026 · May 11, 2026

New NIH Grant: The RUNX1 Research Program 10th Annual Scientific Conference and Patient Meeting — $10K at Unknown Institution

WHY IT MATTERS

This conference creates a dedicated space for RUNX1-FPD patients and families to connect with leading researchers and clinicians studying their specific condition, which is critical since many people with this disorder face a 35-50% lifetime risk of developing blood cancer.

The National Institutes of Health is funding a conference bringing together researchers, doctors, and patients with RUNX1-FPD, a rare blood disorder where people have a high risk of developing blood cancers. The conference aims to help experts share what they know and work together to improve care and research for this condition.

Project: The RUNX1 Research Program 10th Annual Scientific Conference and Patient Meeting PI: ERICSON, KATRIN Institution: Unknown Institution Funding: $10K Start Date: 2026-05-06 Abstract: PROJECT SUMMARY The main goal of the RUNX1 Research Program 10th Annual Scientific Conference and Patient Meeting is to create a dynamic convening to foster collaboration and provide opportunities for knowledge and data sharing among a diverse set of researchers, clinicians, and patients and their families for a rare disease called RUNX1 familial platelet disorder with predisposition to hematologic malignancies (RUNX1-FPD or FPDMM). Individuals with the disorder have a 35-50% lifetime risk of developing a hematologic malignancy. Of those who develop a malignancy, over 50% are diagnosed with AM

Read the original at nih_reporter
runx1-fpdblood disorderhematologic malignancy riskpatient conferenceresearch collaboration

Related conditions

DDX41-related hematologic malignancy predisposition syndromeFamilial platelet disorder with associated myeloid malignancyOBSOLETE: Hereditary thrombocytopenia-hematological cancer predisposition syndrome